Johnson & Johnson, Drugs | featured news

Johnson & Johnson Ordered to Pay $327 Million

A South Carolina judge ordered Johnson & Johnson to pay the state $327 million in civil penalties after a jury concluded earlier this year the company misled doctors about the safety and effectiveness of antipsychotic Risperdal.

 

J&J recall saga continues with Children's Benadryl

Johnson & Johnson's McNeil unit has begun a voluntary recall of Children's Benadryl allergy tablets, in cherry and grape flavors, citing insufficiencies in the development of the manufacturing process.

 

J&J Heart Drug Provided Little Symptom Benefit

J&J Heart Drug Provided Little Symptom Benefit

Results of a long-awaited clinical trial show J&J's drug nesiritide provides limited relief from breathing problems for patients with acute heart failure.

 

J&J AIDS drug shows promise

J&J AIDS drug shows promise

Two pivotal trials of a Johnson & Johnson experimental HIV drug found it worked as well as an existing drug, with fewer side effects but also with nearly twice as many patients failing to respond to treatment.

 

Johnson & Johnson buys 18 percent stake in Crucell

Health care giant Johnson & Johnson is jumping into the increasingly hot vaccine business by taking an 18 percent stake in Dutch biotechnology company Crucell NV and focusing more on preventive medicine....

 

Infant, children's liquid Tylenol recalled

Johnson & Johnson's McNeil unit is voluntarily recalling 57 lots of infants' and children's liquid Tylenol products because of possible bacterial contamination.

 

J&J to Take Stake in Elan

J&J to Take Stake in Elan

J&J agreed to buy an 18.4% stake in Elan for $1 billion and acquire the rights to much of the Irish biotech company's research into drugs for Alzheimer's disease.

 

Subscribe to this RSS topic: Syndicate content